A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ivacaftor Impurity 25 - Request Quote

Picture of Ivacaftor Impurity 25

Ivacaftor Impurity 25

SZ CAT No:SZ-I015042
CAS No
NA
Mol.F.
C24H28N2O5
Mol.Wt.
424.5
Inv. Status
In Stock
Shipping Condition Ice Pack shipment

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ivacaftor Impurity 25 is chemically N-(4,6-Di- tert-butyl-6- hydroperoxy-3-oxo- cyclohexa-1,4-diene-1- yl)-4-oxo-1,4-dihydro-quinoline-3-carboxyamide. Ivacaftor Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Ivacaftor Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ivacaftor.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ivacaftor Impurity 25

Purchase Ivacaftor Impurity 25

Ivacaftor Impurity 25 suppliers

Ivacaftor Impurity 25 manufacturers

Ivacaftor Impurity 25 price

Order Ivacaftor Impurity 25

Enquire Ivacaftor Impurity 25

Ivacaftor Impurity 25 cost

Ivacaftor Impurity 25 Supplier

Ivacaftor Impurity 25 Distributor

Ivacaftor Impurity 25 for Method Validation

Ivacaftor Reference Standard

Ivacaftor Impurity 25 for ANDA Filing

Ivacaftor Impurity 25 for Forced Degradation Studies

Ivacaftor Impurity 25 Identification Standards

Ivacaftor Impurity 25 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,